The effect of the CYP1A1*2A variant on colorectal cancer susceptibility in a British population

被引:0
作者
Oztas, E. [1 ]
Ozhan, G. [1 ]
Daly, A. K. [2 ]
机构
[1] Istanbul Univ, Fac Pharm, Dept Pharmaceut Toxicol, Istanbul, Turkey
[2] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England
关键词
D O I
10.1016/S0959-8049(16)61528-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
670
引用
收藏
页码:S149 / S150
页数:2
相关论文
共 50 条
  • [31] Genetic polymorphism of the CYP1A1, CYP2E1, GSTM1 and GSTT1 genes and lung cancer susceptibility in a north Indian population
    R.C. Sobti
    S. Sharma
    A. Joshi
    S.K. Jindal
    A. Janmeja
    Molecular and Cellular Biochemistry, 2004, 266 : 1 - 9
  • [32] CYP1A1 GENETIC POLYMORPHISMS AND IN-SITU COLORECTAL-CANCER
    SIVARAMAN, L
    LEATHAM, MP
    YEE, J
    WILKENS, LR
    LAN, AF
    LEMARCHAND, L
    CANCER RESEARCH, 1994, 54 (14) : 3692 - 3695
  • [33] Dietary flavonoids, CYP1A1 genetic variants, and the risk of colorectal cancer
    Kim, Jeongseon
    Cho, Young Ae
    Lee, Jeonghee
    Oh, Jae Hwan
    Sohn, Dae Kyung
    Chang, Hee Jin
    CANCER RESEARCH, 2017, 77
  • [34] CYP1A1 m1 and m2 polymorphisms: genetic susceptibility to lung cancer
    Mota, Paula
    Moura, David Silva
    Vale, Maria Graca
    Coimbra, Henriqueta
    Carvalho, Lina
    Regateiro, Fernando
    REVISTA PORTUGUESA DE PNEUMOLOGIA, 2010, 16 (01) : 89 - 98
  • [35] Associations of CYP1A1, GSTM1 and GSTT1 Polymorphisms with Lung Cancer Susceptibility in a Northern Indian Population
    Shukla, R. K.
    Tilak, A. R.
    Kumar, C.
    Kant, S.
    Kumar, A.
    Mittal, B.
    Bhattacharya, S.
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2013, 14 (05) : 3345 - 3349
  • [36] CYP1A1 M2 (A2455G) Polymorphism with Susceptibility to Breast Cancer
    Joob, Beuy
    Wiwanitkit, Viroj
    INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE, 2020, 11 (01)
  • [37] Genetic Variations in the Xenobiotic-Metabolizing Enzymes CYP1A1, CYP1A2, CYP2C9, CYP2C19 and Susceptibility to Colorectal Cancer Among Turkish People
    Ozhan, Gul
    Mutur, Mine
    Ercan, Gulcin
    Alpertunga, Buket
    GENETIC TESTING AND MOLECULAR BIOMARKERS, 2014, 18 (04) : 223 - 228
  • [38] Defining the Contribution of CYP1A1 and CYP1A2 to Drug Metabolism Using Humanized CYP1A1/1A2 and Cyp1a1/Cyp1a2 Knockout Mice
    Kapelyukh, Y.
    Henderson, C. J.
    Scheer, N.
    Rode, A.
    Wolf, C. R.
    DRUG METABOLISM AND DISPOSITION, 2019, 47 (08) : 907 - 918
  • [39] CYP2D6 and CYP1A1 mutations in the Turkish population
    Aydin, M
    Hatirnaz, O
    Erensoy, N
    Ozbek, U
    CELL BIOCHEMISTRY AND FUNCTION, 2005, 23 (02) : 133 - 135
  • [40] A case-control study of CYP2E1 (PstI) and CYP1A1 (MspI) polymorphisms in colorectal cancer
    Proenca, M. A.
    Fernandes, G. M. M.
    Russo, A.
    Lelis, R. B.
    Netinho, J. G.
    Cunrath, G. S.
    Silva, A. E.
    Goloni-Bertollo, E. M.
    Pavarino, E. C.
    GENETICS AND MOLECULAR RESEARCH, 2015, 14 (04) : 17856 - 17863